Home AbbVie

AbbVie

In operation
IPO
Innovative Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

AbbVie is a biopharmaceutical company, and our mission is to discover and deliver innovative medicines to address today's serious health issues and meet future medical challenges. We are committed to developing and marketing advanced therapies focused on treating rheumatology, gastroenterology, dermatology, oncology, virology, neurology, and other metabolism-related severe diseases.
AbbVie Inc.
Chicago,Illinois,United States of America
more than 500 people
January 01, 2013
customerservice@abbvie.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Immune Cell Therapy Gene Therapy Biological Drug Production
Technology
Gene Technology Targeted Technology Immunological Techniques Cell Technology Protein Technology
Concept
Department of Rheumatology and Immunology Dermatology Department Metabolic Diseases Digestive System Diseases Skin Diseases Therapeutic Products Lung Cancer Gastric Cancer Esophageal Cancer Lymphoma Leukemia Lupus Erythematosus Depression
Application Scenarios
Medical Aesthetics Chemical Drug Innovative Drugs Monoclonal Antibody Bispecific Antibody ADC (Antibody-Drug Conjugate) Cell and Gene Therapy High-Value Medical Consumables

LinkedIn